Complementary Assets, Strategic Alliances, and the Incumbent's Advantage: An Empirical Study of Industry and Firm Effects in the Biopharmaceutical Industry
- Topics:
- Strategic Management Tools
- Tags:
- Asset,
- Strategic Alliance,
- Product Marketing,
- Operational Planning,
- Marketing,
- Management,
- Industry,
- Incumbent,
- Business Operations,
- Asset Management,
- ...
- Source:
- Reed Elsevier
FREE Registration is required
Overview: This paper argues that incumbents may be in a position to adapt to radical technological change via inter-firm cooperation with new entrants when the incumbents have complementary assets within their firm boundaries that are critical to commercializing the new technology. It studies 889 strategic alliances of pharmaceutical companies with new biotechnology firms. It finds that an incumbent's alliances with providers of the new technology are positively associated with the incumbent's new product development and, in turn, new product development is positively associated with firm performance.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: PDF | Size: 215KB | Date: Oct 2000 | Pages: 17





